ESC Professional Premium Access

Nationwide observational study of antithrombotic treatment strategies after coronary artery bypass graft surgery in patients with atrial fibrillation

Congress Presentation

About the speaker

Doctor Mia Ravn Jacobsen

Copenhagen (Denmark)
0 follower

7 more presentations in this session

Ischemic and non-ischemic stroke reported in DOAC treated patients with atrial fibrillation and levetiracetam drug interaction: a real-world study

Speaker: Doctor M. Abou Kaoud (Tel Aviv, IL)

Thumbnail

Optimal adherence threshold to non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation to reduce the risk of thromboembolism and death

Speaker: Mr M. Grymonprez (Gent, BE)

Thumbnail

Clinical impact of switching or continuation of apixaban or rivaroxaban among patients with non-valvular atrial fibrillation

Speaker: Doctor S. Deitelzweig (New Orleans, US)

Thumbnail

Risk and benefits of baseline antiplatelet therapy in 58,598 patients with atrial fibrillation randomized to NOACs vs warfarin

Speaker: Doctor S. Patel (Boston, US)

Thumbnail

Comparisons of effectiveness and safety between different dosage strategy in patients with atrial fibrillation treated with rivaroxaban: a systemic review and meta-analysis

Speaker: Doctor T. Chao (Taipei, TW)

Thumbnail

Access the full session

Oral anticoagulation in patients with atrial fibrillation

Speakers: Doctor M. Jacobsen, Doctor M. Abou Kaoud, Mr M. Grymonprez, Doctor S. Deitelzweig, Doctor S. Patel...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations